Effect of Oral Anticoagulants in Atrial Fibrillation Patients with Polypharmacy: A Meta-analysis
Article 2023 en
Authors
YZ
Yuxiang Zheng
SL
Siyuan Li
XL
Xiao Liu
Abstract
1 min read
In patients with AF and polypharmacy, NOACs showed advantages over VKAs in stroke or systemic embolism and any bleeding, and were comparable to VKAs for major bleeding, ischemic stroke, all-cause death, intracranial hemorrhage, and gastrointestinal bleeding.
Discussion(0)
No comments yet. Be the first to comment.